Evidence map›Paper›PMID 35234540›Full record

ArticleTechnology in cancer research & treatment

Development and Validation of a Concise Prediction Scoring System for Asian Lung Cancer Patients with

Wenting An, Wei Fan, Feiyang Zhong, Binchen Wang, Shan Wang, Tian Gan, Sufang Tian, Meiyan Liao

Open access · goldAbstract read
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Ethnic disparities in survival and progression among EGFR-mutated adenocarcinoma of lung cancer patients treated with tyrosine kinase inhibitors: a systematic review and meta-analysis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Wenting An89674Zhongnan Hospital of Wuhan University, Wuhan, China.
Wei Fan89674Zhongnan Hospital of Wuhan University, Wuhan, China.
Feiyang Zhong89674Zhongnan Hospital of Wuhan University, Wuhan, China.
Binchen Wang89674Zhongnan Hospital of Wuhan University, Wuhan, China.
Shan Wang89674Zhongnan Hospital of Wuhan University, Wuhan, China.
Tian Gan89674Zhongnan Hospital of Wuhan University, Wuhan, China.
Sufang Tian89674Zhongnan Hospital of Wuhan University, Wuhan, China.
Meiyan Liao89674Zhongnan Hospital of Wuhan University, Wuhan, China.ORCID 0000-0002-9515-6635
Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lung NeoplasmsAsian PeopleErbB ReceptorsHumansMutationRetrospective StudiesEGFR protein, humanErbB Receptorsepidermal growth factor receptorlung cancerpredictive modelscoring system

Identifiers

PMID35234540
PMCPMC8894628
OpenAlexW4214839409

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.